BOSTON, March 19, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (formerly Galecto, Inc.) (“Damora” or the “Company”) (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care ...
-- DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in ...
BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced ...
Investing.com -- Damora Therapeutics Inc (NASDAQ:DMRA) shares jumped 15.5% Monday following the announcement of Jennifer Jarrett as President and Chief Executive Officer, effective March 30, 2026.
-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- -- Peter ...
Teen / Fantasy Violence, Mild Suggestive Themes, Simulated Gambling, In-Game Purchases (Includes Random Items), Users Interact ...
In a stunning reversal that has sent shockwaves through the motorsport world, the storied German motorsports powerhouse Porsche has recently announced its withdrawal from the FIA World Endurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results